December 20, 2018  |  Announcements

Our CEO’s Top Observations from ASH 2018

headshot_dave800pxAsh-Image-6

This month, we were pleased to exhibit at the annual meeting for the American Society for Hematology (ASH), the most comprehensive hematology event of the year. We were excited to witness firsthand the rapid development of immunotherapy and the use of cutting-edge technologies (including Cytobank) being used by leaders in hematology from around the world.

The main trends I observed at ASH relevant to the research we support were: More »